NCT03977402 Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
| NCT ID | NCT03977402 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New Mexico Cancer Research Alliance |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 47,500 participants |
| Start Date | 2016-01-27 |
| Primary Completion | 2036-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 47,500 participants in total. It began in 2016-01-27 with a primary completion date of 2036-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older. * Has a diagnosis of cancer or is suspected of having cancer. * Able to understand and sign the Informed Consent form directly. * Pregnant women are permitted to be enrolled. Exclusion Criteria: * Prisoners
Contact & Investigator
Leslie Andritsos, MD
PRINCIPAL INVESTIGATOR
University of New Mexico Cancer Center
Frequently Asked Questions
Who can join the NCT03977402 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03977402 currently recruiting?
Yes, NCT03977402 is actively recruiting participants. Contact the research team at CSerway@salud.unm.edu for enrollment information.
Where is the NCT03977402 trial being conducted?
This trial is being conducted at Albuquerque, United States.
Who is sponsoring the NCT03977402 clinical trial?
NCT03977402 is sponsored by New Mexico Cancer Research Alliance. The principal investigator is Leslie Andritsos, MD at University of New Mexico Cancer Center. The trial plans to enroll 47,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.